• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

p53肿瘤抑制蛋白的抗菌活性——证据有多确凿?

Antibacterial Activity of the p53 Tumor Suppressor Protein-How Strong Is the Evidence?

作者信息

Gdowicz-Kłosok Agnieszka, Krześniak Małgorzata, Łasut-Szyszka Barbara, Butkiewicz Dorota, Rusin Marek

机构信息

Center for Translational Research and Molecular Biology of Cancer, Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice Branch, 44-101 Gliwice, Poland.

出版信息

Int J Mol Sci. 2025 May 6;26(9):4416. doi: 10.3390/ijms26094416.

DOI:10.3390/ijms26094416
PMID:40362653
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12072856/
Abstract

The p53 tumor suppressor is best known for controlling the cell cycle, apoptosis, DNA repair, and metabolism, but it also regulates immunity and is able to impede the live cycle of viruses. For this reason, these infectious agents encode proteins which inactivate p53. However, what is less known is that p53 can also be inactivated by human pathogenic bacteria. It is probably not due to collateral damage, but specific targeting, because p53 could interfere with their multiplication. The mechanisms of the antibacterial activity of p53 are poorly known. However, they can be inferred from the results of high-throughput studies, which have identified more than a thousand p53-activated genes. As it turns out, many of these genes code proteins which have proven or plausible antibacterial functions like the efficient detection of bacteria by pattern recognition receptors, the induction of pro-inflammatory pyroptosis, the recruitment of immune cells, direct bactericidal activity, and the presentation of bacterial metabolites to lymphocytes. Probably there are more antibacterial, p53-regulated functions which were overlooked because laboratory animals are kept in sterile conditions. In this review, we present the outlines of some intriguing antibacterial mechanisms of p53 which await further exploration. Definitely, this area of research deserves more attention, especially in light of the appearance of antibiotic-resistant bacterial strains.

摘要

p53肿瘤抑制因子最为人所知的是其对细胞周期、细胞凋亡、DNA修复和代谢的调控作用,但它也调节免疫,并且能够阻碍病毒的生命周期。因此,这些感染因子编码使p53失活的蛋白质。然而,鲜为人知的是,p53也会被人类病原菌灭活。这可能并非附带损害,而是特异性靶向作用,因为p53可能会干扰它们的繁殖。p53抗菌活性的机制尚不清楚。不过,可以从高通量研究的结果中推断出来,这些研究已经鉴定出一千多个p53激活基因。事实证明,其中许多基因编码的蛋白质具有已被证实或可能的抗菌功能,如通过模式识别受体有效检测细菌、诱导促炎性细胞焦亡、募集免疫细胞、直接杀菌活性以及将细菌代谢产物呈递给淋巴细胞。可能还有更多p53调节的抗菌功能被忽视了,因为实验动物是在无菌条件下饲养的。在这篇综述中,我们概述了p53一些有趣的抗菌机制,有待进一步探索。当然,这一研究领域值得更多关注,尤其是鉴于抗生素耐药菌株的出现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f473/12072856/3fc2178d94c2/ijms-26-04416-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f473/12072856/dd30b22c0a7c/ijms-26-04416-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f473/12072856/dce9ac181f9b/ijms-26-04416-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f473/12072856/bc084bcadbb9/ijms-26-04416-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f473/12072856/3fc2178d94c2/ijms-26-04416-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f473/12072856/dd30b22c0a7c/ijms-26-04416-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f473/12072856/dce9ac181f9b/ijms-26-04416-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f473/12072856/bc084bcadbb9/ijms-26-04416-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f473/12072856/3fc2178d94c2/ijms-26-04416-g004.jpg

相似文献

1
Antibacterial Activity of the p53 Tumor Suppressor Protein-How Strong Is the Evidence?p53肿瘤抑制蛋白的抗菌活性——证据有多确凿?
Int J Mol Sci. 2025 May 6;26(9):4416. doi: 10.3390/ijms26094416.
2
The Wheel of p53 Helps to Drive the Immune System.p53 之轮助力驱动免疫系统。
Int J Mol Sci. 2023 Apr 21;24(8):7645. doi: 10.3390/ijms24087645.
3
Mouse double minute antagonist Nutlin-3a enhances chemotherapy-induced apoptosis in cancer cells with mutant p53 by activating E2F1.小鼠双微体拮抗剂Nutlin-3a通过激活E2F1增强化疗诱导的p53突变癌细胞凋亡。
Oncogene. 2007 May 24;26(24):3473-81. doi: 10.1038/sj.onc.1210136. Epub 2006 Dec 4.
4
Modulation of p53 during bacterial infections.细菌感染过程中 p53 的调节。
Nat Rev Microbiol. 2015 Dec;13(12):741-8. doi: 10.1038/nrmicro3537. Epub 2015 Nov 9.
5
Strong activation of p53 by actinomycin D and nutlin-3a overcomes the resistance of cancer cells to the pro-apoptotic activity of the FAS ligand.放线菌素 D 和 nutlin-3a 的强烈激活克服了癌细胞对 Fas 配体促凋亡活性的抗性。
Apoptosis. 2024 Oct;29(9-10):1515-1528. doi: 10.1007/s10495-024-02000-0. Epub 2024 Jul 28.
6
Restoration of p53 pathway by nutlin-3 induces cell cycle arrest and apoptosis in human rhabdomyosarcoma cells.Nutlin-3恢复p53信号通路可诱导人横纹肌肉瘤细胞的细胞周期停滞和凋亡。
Clin Cancer Res. 2009 Jun 15;15(12):4077-84. doi: 10.1158/1078-0432.CCR-08-2955. Epub 2009 Jun 9.
7
Activation of the p53 pathway by the MDM2 inhibitor nutlin-3a overcomes BCL2 overexpression in a preclinical model of diffuse large B-cell lymphoma associated with t(14;18)(q32;q21).MDM2 抑制剂 nutlin-3a 通过激活 p53 通路克服了 t(14;18)(q32;q21)相关弥漫性大 B 细胞淋巴瘤中 BCL2 过表达的表型。
Leukemia. 2011 May;25(5):856-67. doi: 10.1038/leu.2011.28. Epub 2011 Mar 11.
8
Transcriptomic and proteomic study of cancer cell lines exposed to actinomycin D and nutlin-3a reveals numerous, novel candidates for p53-regulated genes.对暴露于放线菌素D和Nutlin-3a的癌细胞系进行转录组学和蛋白质组学研究,揭示了众多新的p53调控基因候选者。
Chem Biol Interact. 2024 Apr 1;392:110946. doi: 10.1016/j.cbi.2024.110946. Epub 2024 Mar 7.
9
Actinomycin D and nutlin-3a synergistically promote phosphorylation of p53 on serine 46 in cancer cell lines of different origin.放线菌素D和Nutlin-3a协同促进不同来源癌细胞系中p53丝氨酸46位点的磷酸化。
Cell Signal. 2015 Sep;27(9):1677-87. doi: 10.1016/j.cellsig.2015.05.005. Epub 2015 May 16.
10
Inhibition of p53-murine double minute 2 interaction by nutlin-3A stabilizes p53 and induces cell cycle arrest and apoptosis in Hodgkin lymphoma.Nutlin-3A对p53与鼠双微体2相互作用的抑制作用可使p53稳定,并诱导霍奇金淋巴瘤细胞发生细胞周期阻滞和凋亡。
Clin Cancer Res. 2007 Jun 1;13(11):3380-7. doi: 10.1158/1078-0432.CCR-06-2581.

本文引用的文献

1
p53-regulated non-apoptotic cell death pathways and their relevance in cancer and other diseases.p53调控的非凋亡性细胞死亡途径及其在癌症和其他疾病中的相关性。
Nat Rev Mol Cell Biol. 2025 Apr 9. doi: 10.1038/s41580-025-00842-3.
2
MHC-related protein 1-restricted recognition of cancer via a semi-invariant TCR-α chain.通过半不变TCR-α链实现与MHC相关蛋白1限制的癌症识别。
J Clin Invest. 2025 Jan 2;135(1):e181895. doi: 10.1172/JCI181895.
3
Comparison of Different Keratinocyte Cell Line Models for Analysis of NLRP1 Inflammasome Activation.
不同角质形成细胞系模型分析 NLRP1 炎性小体激活的比较。
Biomolecules. 2024 Nov 8;14(11):1427. doi: 10.3390/biom14111427.
4
co-cultured with oral cancer cells exhibits higher virulence and promotes cancer cell survival, proliferation, and migration: an study.与口腔癌细胞共培养表现出更高的毒力,并促进癌细胞的存活、增殖和迁移:一项 研究。
J Med Microbiol. 2024 Nov;73(11). doi: 10.1099/jmm.0.001931.
5
p53 target ANKRA2 cooperates with RFX7 to regulate tumor suppressor genes.p53靶基因ANKRA2与RFX7协同调控肿瘤抑制基因。
Cell Death Discov. 2024 Aug 24;10(1):376. doi: 10.1038/s41420-024-02149-2.
6
Comparative host transcriptomics as a tool to identify candidate biomarkers for immune reactions in leprosy using meta-analysis.比较宿主转录组学作为一种工具,通过元分析来识别麻风病免疫反应的候选生物标志物。
Indian J Dermatol Venereol Leprol. 2024 Nov-Dec;90(6):731-741. doi: 10.25259/IJDVL_532_2022.
7
Mucosal associated invariant T cells: Powerhouses of the lung.黏膜相关恒定 T 细胞:肺部的动力源。
Immunol Lett. 2024 Oct;269:106910. doi: 10.1016/j.imlet.2024.106910. Epub 2024 Aug 10.
8
Strong activation of p53 by actinomycin D and nutlin-3a overcomes the resistance of cancer cells to the pro-apoptotic activity of the FAS ligand.放线菌素 D 和 nutlin-3a 的强烈激活克服了癌细胞对 Fas 配体促凋亡活性的抗性。
Apoptosis. 2024 Oct;29(9-10):1515-1528. doi: 10.1007/s10495-024-02000-0. Epub 2024 Jul 28.
9
The p53 protein - not only the guardian of the genome.p53 蛋白——不仅仅是基因组的守护者。
Postepy Biochem. 2024 May 23;70(1):71-87. doi: 10.18388/pb.2021_518.
10
Determinants of p53 DNA binding, gene regulation, and cell fate decisions.p53 基因的 DNA 结合、基因调控和细胞命运决定的决定因素。
Cell Death Differ. 2024 Jul;31(7):836-843. doi: 10.1038/s41418-024-01326-1. Epub 2024 Jun 29.